Filing Details

Accession Number:
0001179110-20-001421
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-10 19:24:31
Reporting Period:
2020-02-06
Accepted Time:
2020-02-10 19:24:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203346 Doug G Iiekking 3838 West Parkway Blvd
Salt Lake City UT 84120
Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-06 1,395 $70.75 3,654 No 4 M Direct
Common Stock Disposition 2020-02-06 1,395 $78.65 2,259 No 4 S Direct
Common Stock Disposition 2020-02-10 2,259 $83.44 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock - Settles Stock Appreciation Right Disposition 2020-02-06 15,000 $0.00 15,000 $70.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-09-01 2020-03-01 No 4 M Direct
Footnotes
  1. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.
  2. Weighted average price $83.4444. Price range in multiple transactions was $83.41 to $83.50 inclusively.